Equities

Standard Chem & Pharm Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
1720:TAI

Standard Chem & Pharm Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (TWD)60.70
  • Today's Change-0.10 / -0.16%
  • Shares traded271.77k
  • 1 Year change-0.65%
  • Beta0.0185
Data delayed at least 20 minutes, as of Feb 11 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Standard Chem & Pharm Co Ltd is a Taiwan-based company principally engaged in the manufacture and sales of western pharmaceuticals, dietary supplement and active pharmaceutical ingredients. The Company’s products cover circulatory system drugs, digestive system drugs, respiratory system drugs, nervous system drugs, metabolic drugs and general foods and health foods. The Company is also engaged in the sales of medical equipment, animal medicine, cosmetics and milk powder. The Company's products are sold to domestic and overseas markets.

  • Revenue in TWD (TTM)6.91bn
  • Net income in TWD893.09m
  • Incorporated1967
  • Employees1.13k
  • Location
    Standard Chem & Pharm Co LtdNo.6-20Tuku, Tuku Village, Sinying DistrictTAINAN 730TaiwanTWN
  • Phone+886 66361516
  • Fax+886 66352817
  • Websitehttps://www.standard.com.tw/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Sinphar Pharmaceutical Co Ltd3.35bn345.57m5.81bn984.0016.841.769.871.741.811.8117.5717.390.54012.536.94--5.401.397.001.9142.5137.5910.003.111.5613.850.318869.666.335.64-18.7885.267.7540.11
SCI Pharmtech Inc1.39bn115.35m6.21bn241.0054.041.1617.004.470.96230.962311.6144.940.19741.604.99--1.645.961.897.0524.9135.308.3021.640.38412.560.150625.2426.54-8.3481.42-1.3135.86-18.67
Formosa Laboratories Inc4.90bn240.77m6.82bn480.0028.590.89489.231.391.981.9840.6363.360.35651.565.42--1.472.652.013.6041.8438.164.128.391.231.590.290841.088.5011.3824.5868.35-16.19--
Adimmune Corp1.20bn-508.60m7.75bn564.00--1.61--6.45-1.21-1.212.8511.210.14131.432.11---7.070.5893-8.860.67422.6732.30-50.052.711.42-49.730.402831.00-12.783.6862.06---15.71--
Standard Chem & Pharm Co Ltd6.91bn893.09m10.85bn1.13k12.161.826.561.574.994.9938.6333.290.60662.485.98--10.8010.4819.1819.4242.1443.8617.8118.241.69--0.103458.438.8111.515.4618.5227.4213.30
YungShin Global Holding Corp8.37bn963.10m14.73bn1.57k15.301.8911.141.763.613.6131.4229.230.65841.626.24--8.047.4211.0910.9943.3344.5412.2111.842.1427.060.123669.0014.29-0.392841.249.31-18.326.40
Data as of Feb 11 2026. Currency figures normalised to Standard Chem & Pharm Co Ltd's reporting currency: Taiwan Dollar TWD

Institutional shareholders

1.28%Per cent of shares held by top holders
HolderShares% Held
Dimensional Fund Advisors LPas of 08 Jan 20261.95m1.09%
Dimensional Fund Advisors Ltd.as of 30 Nov 2025110.09k0.06%
SSgA Funds Management, Inc.as of 08 Jan 202664.00k0.04%
Franklin Templeton SinoAm Securities Investment Mgmt, Incas of 09 Jan 202663.00k0.04%
RAM Active Investments SAas of 30 Jun 202530.79k0.02%
DFA Australia Ltd.as of 31 Dec 202530.62k0.02%
American Century Investment Management, Inc.as of 08 Jan 202619.00k0.01%
LGT Capital Partners AG (Investment Management)as of 31 May 202512.00k0.01%
CI Investments, Inc.as of 30 Jun 20253.77k0.00%
More ▼
Data from 30 Jun 2025 - 23 Jan 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.